Beijing Xutang Biotech (BXB), founded in 2022 and headquartered in Beijing, China, is a high-tech biomedicine company established by Zhou Ning (Yu Jun) with RMB 130 million registered capital. Built on 30+ years of research, BXB has developed a leading herbal nanomedicine platform integrating extraction, purification, and targeted delivery technologies. The Group collaborates with the National Cancer Centre of China and the China Academy of Chinese Medical Sciences, and is committed to advancing healthcare innovation and modernising traditional Chinese medicine.